Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma

Background ARID1B, which exists as a mutually exclusive isoform with ARID1A in the SWI/SNF chromatin remodeling complex, has been recently identified as a major mutant gene in a wide variety of cancers. The present study aimed to determine the association between ARID1B expression and outcomes, as w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Beihe, Xie, Huyang, Ma, Chunguang, Zhang, Guiming, Gan, Hualei, Wang, Qifeng, Liu, Xiaohang, Zhu, Yiping, Zhu, Yao, Shi, Guohai, Zhang, Hailiang, Dai, Bo, Shen, Yijun, Ye, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687163/
https://www.ncbi.nlm.nih.gov/pubmed/29151933
http://dx.doi.org/10.7150/jca.19109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687163/
https://www.ncbi.nlm.nih.gov/pubmed/29151933
http://dx.doi.org/10.7150/jca.19109

Ejemplares similares